On August 2, 2021 Replimune Group, Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic platform, reported that members from the Replimune management team will present and host investor meetings at the following two conferences (Press release, Replimune, AUG 2, 2021, View Source [SID1234585513]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
BTIG Virtual Biotechnology Conference 2021
Date: Monday, August 9, 2021
Presentation Time: 11:00 am ET
2021 Wedbush PacGrow Healthcare Virtual Conference
Panel: For Your IOnly – Progress, Challenges in Immuno-Oncology
Date: Wednesday, August 11, 2021
Presentation Time: 12:35 pm ET